DMAC vs FAST
DiaMedica Therapeutics Inc (DMAC) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Fastenal Company (FAST) is a industrial distribution company listed on US.
DMAC does not have a complete income-statement cache yet.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
DMAC currently screens at market cap $157.4M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the DMAC and FAST stock pages for the full models.
Not investment advice.